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Abstract: Infections with the intestinal protozoan parasite Giardia in dogs and cats are common. Clinical
signs vary from asymptomatic to small bowel diarrhea and associated discomfort. The control of infections
in dogs is frequently a frustrating issue for animal owners and veterinarians. Drugs with antiprotozoal
activity such as fenbendazole and metronidazole are recommended, however, they do not show 100%
efficacy and superinfections occur regularly. Ronidazole is currently the drug of choice for the treatment
of Tritrichomonas foetus in cats and there is now limited information available about its efficacy against
Giardia spp. In the kennel investigated, dogs regularly showed loose feces and the presence of Giardia
(assemblage C, renamed as G. canis) cysts. An elimination strategy of this parasite involving strict
hygiene management and disinfection of the enclosures with 4-chlorine-M-cresol, oral treatment with
ronidazole (30-50mg/kg BW bid for 7 days) and two shampooings (containing chlorhexidine) at the
beginning and the end of the treatments was implemented for a group of 6 dogs. As a control another
group of 7 dogs was transferred to the disinfected enclosures and shampooed, but left untreated. Dog
feces were tested for the presence of Giardia cysts (SAF concentration technique) or Giardia antigen with
a commercial ELISA (NOVITEC(®)) and a quick immunochromatography-based test (SensPERT(®))
before and between 5 and 40 days after the last treatment. All ronidazole-treated dogs were negative for
Giardia cysts and antigen up to 26 days after the last treatment, while between 1 and 5 of the control
animals tested positive in each of the test series. At this point, also dogs of the control group were again
moved into clean enclosures, shampooed twice and treated with ronidazole. Five, 12 and 19 days after
the last treatment, the dogs in the control group tested negative for Giardia cysts and antigen. However,
all animals had again positive results at later time points in at least one of the three applied diagnostic
techniques within 33-61 days after treatment. Furthermore, all dogs had episodes of diarrhea (for 1-4
days) within 14-31 days after treatment and unformed feces during the whole experiment. The positive
effect of ronidazole against Giardia infections in dogs could be confirmed in this study. In particular, the
combination of ronidazole treatment combined with the disinfection of the environment and shampooing
of the dogs was highly effective in reducing Giardia cyst excretion and may therefore constitute an
alternative control strategy for canine giardiosis.
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Abstract 13 
Infections with the intestinal protozoan parasite Giardia in dogs and cats are common. 14 
Clinical signs vary from asymptomatic to small bowel diarrhoea and associated discomfort. 15 
The control of infections in dogs is frequently a frustrating issue for animal owners and 16 
veterinarians. Drugs with antiprotozoal activity such as fenbendazole and metronidazole are 17 
recommended, however, they do not show 100% efficacy and superinfections occur 18 
regularly. Ronidazole is currently the drug of choice for the treatment of Tritrichomonas 19 
foetus in cats and there is now limited information available about its efficacy against Giardia 20 
spp. In the kennel investigated, dogs regularly showed loose faeces and the presence of 21 
Giardia (assemblage C, renamed as G. canis) cysts. An elimination strategy of this parasite 22 
involving strict hygiene management and disinfection of the enclosures with 4-chlorine-M-23 
cresol, oral treatment with ronidazole (30-50 mg/kg BW bid for 7 days) and two shampooings 24 
(containing chlorhexidine) at the beginning and the end of the treatments was implemented 25 
for a group of 6 dogs. As a control another group of 7 dogs was transferred to the disinfected 26 
enclosures and shampooed, but left untreated. Dog faeces were tested for the presence of 27 
Giardia cysts (SAF concentration technique) or Giardia antigen with a commercial ELISA 28 
(NOVITEC®) and a quick immunochromatography-based test (SensPERT®) before and 29 
between 5 and 40 days after the last treatment. All ronidazole-treated dogs were negative for 30 
Giardia cysts and antigen up to 26 days after the last treatment, while between 1 and 5 of the 31 
control animals tested positive in each of the test series. At this point, also dogs of the control 32 
group were again moved into clean enclosures, shampooed twice and treated with 33 
ronidazole. Five, 12 and 19 days after the last treatment, the dogs in the control group tested 34 
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negative for Giardia cysts and antigen. However, all animals had again positive results at 35 
later time points in at least one of the three applied diagnostic techniques within 33-61 days 36 
after treatment. Furthermore, all dogs had episodes of diarrhoea (for 1-4 days) within 14-31 37 
days after treatment and unformed faeces during the whole experiment. The positive effect of 38 
ronidazole against Giardia infections in dogs could be confirmed in this study. In particular, 39 
the combination of ronidazole treatment combined with the disinfection of the environment 40 
and shampooing of the dogs was highly effective in reducing Giardia cysts excretion and 41 
may therefore constitute an alternative control strategy for canine giardiosis.  42 
 43 
 44 





Giardia is an intestinal protozoan with a broad host range in wild and domestic mammals. 48 
Although the adverse consequences of Giardia infection and its pathogenic potential are best 49 
recognized in humans (Thompson, 2004), it is also a well known causative agent of diarrhea 50 
in dogs and cats. Diarrhea is common in both animal species, with many possible causes: 51 
non-infectious (stress, disturbances in water balance, nutritional and immune status, 52 
malnutrition, neoplasia, inflammatory disease) and infectious (bacterial, parasitic, or viral 53 
infections) causes, but also any combination of the above (Payne and Artzer, 2009). Since 54 
stress has an effect on the function and the immunological reactions in the gut, it is not 55 
surprising that high Giardia prevalences were identified among animals housed in stressful 56 
situations such as dog rescue shelters (Upjohn et al., 2010) or kennels (Scaramozzino et al., 57 
2009).  58 
Molecular tools are commonly used for the genetic characterization of Giardia isolates. 59 
Currently, seven Giardia genotypes, designated assemblages and in some cases assigned 60 
distinct species names, are recognized. Dogs are infected by parasites of four assemblages 61 
(A, B, C, D), of which assemblage C and D (also defined as G. canis) are found exclusively 62 
in dogs, while parasites of assemblages A and B (also defined as G. enterica) are zoonotic 63 
(Covacin et al., 2011; Thompson, 2004; Thompson and Monis, 2011).  64 
Giardia cysts are therefore frequently found in routine diagnostic examination of dog faeces, 65 
also from asymptomatic dogs (Covacin et al., 2011). In a recent study performed with 878 66 
shelter dogs (Upjohn et al., 2010), the apparent prevalence of Giardia was 9.9% and the true 67 
prevalence, based on the known sensitivity and specificity of the ELISA test, was 21.0%, 68 
which is in the same range as found in previous studies. Since stress has an effect on the 69 
function and the immunological reactions in the gut, it is not surprising that high Giardia 70 
prevalences were identified among animals housed in stressful situations such as dog 71 
rescue shelters (Upjohn et al., 2010) or kennels (Scaramozzino et al., 2009). In addition, 72 
faecal samples that were graded concerning their consistency, confirmed previous results, 73 
i.e. a weak association between faecal consistency and infection with Giardia in dogs. 74 
Molecular tools are commonly used for the genetic characterization of Giardia isolates. Dogs 75 
are infected by parasites of four assemblages (A, B, C, D), of which assemblage C and D 76 
(also defined as G. canis) are found exclusively in dogs, while parasites of assemblages A 77 
and B (also defined as G. enterica) are zoonotic (Covacin et al., 2011; Thompson, 2004; 78 
Thompson and Monis, 2011). Several compounds have been tested for efficacy against 79 
Giardia infections in dogs, and some of them are frequently employed by veterinary 80 
practitioners. Several benzimidazoles (Barr et al., 1993; Villeneuve et al., 2000), in particular 81 
fenbendazole (Barr et al., 1994), or the combinations of febantel/fenbendazole (febantel is 82 
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metabolized to fenbendazole) with other compounds proved to be effective (Barr et al., 83 
1998). Furthermore, metronidazole, from the class of the nitroimidazoles, is used routinely to 84 
treat giardiosis in dogs and cats. It was argued that this compound is an effective therapy for 85 
diarrhea regardless of the cause, and may be used in combination with fenbendazole to 86 
relieve clinical signs and eliminate parasites (Payne and Artzer, 2009). However, 87 
metronidazole should not be used in doses above 60 mg/kg BW to avoid adverse side 88 
effects (Plumb, 1999). Nitazoxanide, a nitrothiazolyl-salicilamide, has been tested in vitro 89 
(Cedillo-Rivera et al., 2002), while azythromicin, an azalide, has been used for the treatment 90 
of only one dog (Zygner et al., 2008). Therefore, further experiments are required to confirm 91 
the efficacy of these drugs against Giardia infection (Geurden and Olson, 2011). Ronidazole 92 
and tinidazole are also nitroimidazoles, and while the latter has recently been approved in 93 
the United States for the treatment of giardiosis in humans, ronidazole has been used for 94 
treatment of blackhead disease, caused by Histomonas meleagridis in turkeys. In addition, 95 
ronidazole is currently the drug of choice against Tritrichomonas foetus in cats (Gookin et al., 96 
2006). A high antiprotozoic effect was demonstrated in vitro against G. duodenalis with an 97 
approximately five-fold higher activity than metronidazole (Boreham et al., 1985). The same 98 
authors also reported good efficacy of ronidazole against Giardia sp. in mice (Boreham et al., 99 
1986).  100 
Although several compounds are effective against Giardia, control programs combining drug 101 
treatment with cleaning and disinfection of the environment to reduce the environmental 102 
infection pressure are recommended (Geurden and Olson, 2011). Studies showed that 103 
calves as well as dogs re-excreted cysts shortly after the end of antiprotozoic treatment if no 104 
hygienic  measures were implemented (Geurden et al., 2006; Villeneuve et al., 2000). In 105 
addition, thorough shampooing of companion animals is recommended after treatment to 106 
prevent reinfection through faecal material on the fur (Payne et al., 2002; Zajac et al., 1998). 107 
The aim of the present study was to assess the efficacy of ronidazole against Giardia 108 
infections in a dog kennel.  109 
 110 
2. Materials and Methods 111 
2.1  Facility, animals, management 112 
In the animal facilities of the Veterinary Faculty of the University of Zurich, beagle dogs are 113 
housed in groups of 2-4 in pens of 1.45 m x 4.5 m in size with access to an outside run of 114 
1.45 m x 5.5 m. Some adjacent pens share a common outside run of 3 m x 11 m with a 115 
concrete floor. Pens are enriched by installations allowing dogs to jump and use the space 116 
tridimensional, as well as to rest and retreat.  117 
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The total number of dogs in the facility varies between 12 and 42 with an age range between 118 
puppies and 6 years. Dogs are tested regularly (every 3 months) for the presence of 119 
parasites in their feces by sedimentation/flotation and by SAFC-technique (Eckert et al., 120 
2008). For individual faecal samples, dogs are isolated overnight. Occasionally, some dogs 121 
presenting Toxocara canis infections are treated with an anthelmintic compound. Most of the 122 
dogs occasionally show loose faeces but only in some of them Giardia cysts are detected. 123 
Prior to the start of this study, Giardia of the ‘dog genotype’ assemblage C was identified by 124 
PCR/sequencing of part of the 18s rRNA gene (Hopkins et al., 1997). Daily cleaning of the 125 
pens with a cleaning agent (Allzweckreiniger 681, Kärcher AG, CH-8108) is combined with 126 
the use of a disinfectant (Incidin® PLUS, Ecolab GmbH, 4132 Muttenz) twice a week in 127 
dosages according to the instructions of the manufacturers. The dogs are fed once per day 128 
with standard commercial dog food at the recommended rates, while tap water is available in 129 
automatic drinking troughs.  130 
 131 
2.2. Experimental design 132 
In June 2010 a control strategy for Giardia infections, depicted in Fig. 1, was devised. 133 
Thirteen dogs (6 males and 7 females) aged between 13 and 19 months and excreting 134 
Giardia cysts, as confirmed by the SAFC (sodium acetate – acetic acid - formalin 135 
concentration) - technique seven days before the start of the study (study day SD -7), were 136 
included. They were housed in groups and separated from the other dogs of the facility by 137 
leaving empty boxes in between. At SD -2, the pens of all dogs in the study were disinfected 138 
(including floors, walls and installations) with 4-chlorine-M-cresol (Neopredisan® 135-1, Vital 139 
AG, Oberentfelden, Switzerland) in a 3% dilution with water, applying approximately 0.4L/ 140 
m2, as recommended for the elimination of coccidia and Cryptosporidium. A minimum of two 141 
hours later, the disinfectant was removed with water at 80° C with a high-pressure cleaner. 142 
During the following SD -1, the surfaces were allowed to dry completely. On the same day, 143 
all dogs were showered with warm water and shampooed with 4% chlorhexidine digluconate 144 
(Clorexyderm® 4%, ufamed AG, Sursee, Switzerland), which was left for 5-7 min as 145 
recommended. Afterwards, the solution was washed off the dog’s fur, and the animals were 146 
brought directly to the previously disinfected and dried enclosures. Drug treatment was 147 
initiated at SD 0 with six dogs (therapeutic group) selected on the basis of their previous 148 
housing (dogs housed together or housed close to each other): ronidazole (30-50 mg/kg BW 149 
bid for 7 days, SD 0-6) was orally administered in capsules, which were specially prepared 150 
by a pharmacist (Christoffel-Apotheke, Bern). The control group (7 dogs) was left untreated. 151 
On SD 6, all dogs were again washed and shampooed, and the enclosures were again 152 
cleaned, disinfected and dried the day before as described previously. All dogs were moved 153 
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back to the cleaned enclosures on SD 6. Animal caretakers were instructed to change shoes 154 
every time they entered the disinfected sector of the facility. 155 
Starting on SD 47 the same protocol was repeated with exception of treatment, which was 156 
implemented for the control dogs this time: disinfection of the facilities and shampooing of all 157 
dogs twice (before and towards the end of the 7-day treatment of the control dogs with 158 
ronidazole,  Fig. 1). 159 
 160 
2.3.  Diagnostic methods 161 
Individual faecal samples were collected on SD 11, 14, 18, 25, 32, 39 and 46, corresponding 162 
to 5, 8, 12, 19, 26, 33 and 40 days after receiving the last dose of ronidazole treatment in the 163 
therapeutic group. Both groups were also followed-up by faecal examinations at SD 60, 67 164 
and 74, corresponding to 5, 12 and 19 days after the last treatment in the control group. 165 
Dog faeces were tested at the diagnostics unit of the Institute of Parasitology, Zurich, for the 166 
presence of Giardia cysts (SAFC technique) and Giardia antigen with a commercial ELISA 167 
(NOVITEC®, Diagnostic GmbH, Freiburg, Germany). The laboratory and the method are 168 
accredited by norm ISO/IEC 17025 for human and animal samples. In addition, a quick test 169 
based on immunochromatography (SensPERT®, VetAll Laboratories, Kyunggi-Do, South 170 
Korea) was performed according to the manufacturers’ instructions. ELISA results were 171 
correspondingly graded from 0 (negative) to 4 (very high-grade positive) based on optical 172 
density values adjusted to the positive and negative controls, while the 173 





An overview of the coproscopic results is given in Tab. 1. All faecal samples of dogs in the 179 
treatment group were negative for Giardia cysts and coproantigens 11 days after the last 180 
treatment and remained negative on further four investigations up to SD 32. However, on SD 181 
39 (33 days after the end of the therapy) one dog tested coproantigen positive and on SD 46 182 
4 dogs tested coproantigen positive. The first excretion of cysts was detected on SD 60 in 183 
one dog. In the following days (up to SD 74, i.e. 33-54 days after the last treatment) all dogs 184 
of this group tested positive in at least one of the tests applied.  185 
In the control group, 1-5 dogs tested regularly positive in at least one of the three applied 186 
diagnostic techniques until SD 46. When these control dogs were moved into clean 187 
enclosures and treated with ronidazole (at SD 49-55) and shampooed twice, they were 188 
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already negative for Giardia cysts and coproantigens 5 days after the last treatment. In the 189 
follow-up until SD 74 the dogs remained negative. 190 
Several dogs had episodes of unformed faeces and diarrhea (for 1-2 days) during the entire 191 
experiment albeit without a temporal correlation with ronidazole treatments.  192 
 193 
4. Discussion 194 
The results presented here confirmed a good antiprotozoic effect of ronidazole against 195 
Giardia in dogs as shown previously in vitro or in a mouse model (Boreham et al., 1985, 196 
1986). As no information was available about the use of ronidazole in dogs, the same dose 197 
as for cats against T. foetus was adopted for this trial, i.e. 30-50 mg/kg BW bid for 7 days. 198 
The dosage of nitroimidazole compounds, especially metronidazole, needs particular 199 
consideration, since a considerable number of significant side-effects such as nausea, 200 
diarrhea, anorexia and neutropenia may occur when administered to humans or animals 201 
(Payne and Artzer, 2009; Plumb, 1999). In our study diarrheic episodes were monitored in 202 
treated and untreated dogs and can therefore not be correlated with ronidazole treatment. 203 
Stress, active Giardia infections and many other factors may be the cause for the observed 204 
faecal alterations.  205 
Giardia has been described as “one of the most commonly misdiagnosed, underdiagnosed, 206 
and overdiagnosed parasites in veterinary practices today” (Payne and Artzer, 2009). Cysts 207 
are shed intermittently, and therefore repeated faecal analyses may be needed before cysts 208 
are recovered in a sample if the SAFC-technique is applied. This method can be considered 209 
as a gold standard technique and is being applied routinely for Giardia cyst detection in many 210 
diagnostic laboratories. However, the identification of the small cysts is challenging for 211 
personnel with little experience. In our study the NOVITEC® ELISA results were quantified 212 
as proposed by the manufacturer. In samples with high cyst abundance, positive results were 213 
also obtained with the other two techniques. This confirms the higher sensitivity of these 214 
methods if compared with the SAFC-technique. The additionally performed 215 
immunochromatographic test (SensPERT®) is a rapid test which can be used by veterinary 216 
practitioners. The results show that more positive results were obtained with this test 217 
compared with the SAFC-technique, but fewer than with the ELISA. In addition, some results 218 
were not interpretable because of the insufficient visibility of potential bands; possibly further 219 
development of this test may increase its usefulness in practice.  220 
The adopted ELISA and other easy to use tests available to veterinarians (i.e. the SNAP 221 
Giardia Test for dogs and cats, IDEXX Laboratories, or SensPert®) reliably identify Giardia 222 
spp. cyst antigens (GSA 65 in the Novitec® and a 65 kD cyst antigen in the SensPert® test) 223 
shed with the faeces. Because of inconsistent results of several population and comparative 224 
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studies, it was concluded that none of the methods was 100% reliable and therefore 225 
combined testing methods (Payne and Artzer, 2009) as well as multiple sampling over 226 
several days were suggested to identify true prevalences (Geurden et al., 2008; Thompson, 227 
2004). The current study confirms the irregularity of cyst excretion and differences in the 228 
sensitivity of tests. In concrete situations when diagnosing potentially affected dogs, additive 229 
costs have to be considered in case of combined testing methods. 230 
The combination of ronidazole treatment conjoined with the disinfection of the pens and 231 
shampooing of the dogs had an impact on Giardia cyst excretion: the therapeutic group 232 
started to be positive again only 33 days after the last treatment, and also the control group 233 
remained negative after treatment until the end of the experiment (19 days after the last 234 
treatment).  235 
Although chemotherapy may be highly effective in eliminating Giardia infection, there are 236 
many cases of humans and animals with persisting Giardia cyst excretion which do 237 
apparently not respond to treatment. It was suggested that reinfection is the most common 238 
cause for treatment failure (Payne and Artzer, 2009). Reinfections frequently occur if the 239 
sources of environmental contamination are not eliminated. This applies particularly to 240 
localized endemic foci where environmental infectious pressure is high, for instance in 241 
kennels and catteries (Thompson, 2004). Therefore, in addition to antiprotozoic treatment of 242 
all contact animals, accompanying measures such as bathing after treatment and sanitation 243 
of the environment were recommended before resistance to the medications should be 244 
considered (Payne and Artzer, 2009). Clearly, the high tenacity and the ubiquitous presence 245 
of Giardia cysts play an important role. Giardia cysts are described to survive particularly well 246 
in high humidity and water: for 11 weeks in water at 4 °C (Olson et al., 2004) and up to 84 247 
days in cold river and lake water (deRegnier et al., 1989). Shampooing of the dogs before 248 
and after the treatment with ronidazole aimed at the elimination of Giardia cysts on the fur of 249 
affected animals. Contemporaneously implemented hygiene measures such as two 250 
disinfections of the pens (before and at the end of antiprotozoic treatment) and change of 251 
shoes of the animal caretaker had the aim to prevent reinfections with cysts from the 252 
environment. It was assumed that at the end of an efficacious seven-day antiprotozoic 253 
treatment no additional Giardia cysts should be excreted and therefore the remaining cysts 254 
from the environment had to be inactivated. However, neither chlorhexidine digluconate in 255 
the shampoo nor 4-chlorine-M-cresol in the disinfectant solution are specifically indicated for 256 
elimination of Giardia spp. cyst. As a matter of fact, to our knowledge none of the available 257 
products at the beginning of study was certified and therefore indicated for this purpose. . 258 
Since regular use of detergents and hot, soapy water as recommended for the reduction of 259 
Giardia cysts (Payne and Artzer, 2009) were not able to eliminate the Giardia problem at the 260 
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facility, additional measures were experienced. In particular the product Neopredisan® was 261 
chosen because of its indication for the elimination of infectious Cryptosporidium oocysts, 262 
which are regularly described to be even more difficult to inactivate than Giardia cysts 263 
(Betancourt and Rose, 2004; Korich et al., 1990). Similarly, chlorhexidine digluconate was 264 
the only available disinfectant contained in a dog shampoo and was applied to further 265 
increase the level of hygiene, a factor considered fundamental in Giardia elimination strategy 266 
(Payne and Artzer, 2009). However, since none of the animals were tested with ronidazole 267 
treatment alone or with cleaning or disinfection alone, it cannot be determined which 268 
component was most important to suppress Giardia shedding. Such investigations would be 269 
particularly useful, considering that for most of the dog owners such a strict hygiene 270 
management is simply not feasible, that Giardia cysts are ubiquitous in the environment, and 271 
that most people and animals will be exposed to cysts without becoming ill. Furthermore, the 272 
question arises if it is necessary to treat asymptomatic animals excreting Giardia cysts. In the 273 
past, antiprotozoic treatment of Giardia in dogs and cats, ill or asymptomatic, has been 274 
strongly recommended because of the possible zoonotic risk (Thompson, 2004). The 275 
prevalence of zoonotic assemblages in dogs was recently shown to be subjected to high 276 
variations, depending on the analysed countries and dog populations (Leonhard et al., 2007; 277 
Upjohn et al., 2010) and it was therefore suggested to not draw conclusions from one 278 
geographical region to another in terms of the prevalence or assemblage composition of 279 
Giardia infections in dogs (Covacin et al., 2011). In any case, the awareness about this 280 
potential zoonotic risk was recommended to be maintained for all people involved (Upjohn et 281 
al., 2010).  282 
The combination of an efficient antiprotozoic treatment with accompanying hygienic 283 
measures was able to suppress Giardia excretion for some time in a dog kennel with 284 
controlled management. However, even under restricted conditions in a professionally 285 
conducted dog kennel, reinfections occurred despite all applied hygienic measures. Whether 286 
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Tab. 1: Coproscopic results of six dogs (therapeutic group) treated orally with ronidazole (30-50 mg/kg BW bid) at study day (SD) 0-6 and of seven 
dogs (control group) treated at SD 49-55. Additional measures including strict hygiene management, disinfection of the enclosures and 
shampooing at the beginning and the end of the treatments were applied in both groups. Test methods were: SAFC-technique (S), ELISA 
(NOVITEC®), (E), and a quick test based on immunochromatography, SensPERT®, (P). M= male dogs, F= female dogs.  
 Therapeutic group, treated on SD 0-6 
 SD= 11 SD= 14 SD= 18 SD= 25 SD= 32 SD= 39 SD= 46 SD= 60 SD= 67 SD= 74 
Dog-ID S1 E2 P3 S E P S E P S E P S E P S E P S E P S E P S E P S E P 
5078, M - 0 0 - 0 0 - 0 0 - 0 0 - 0 0 - 0 0 - 0 0 + 2 1 - 1 0 - 1 1 
5085, M - 0 0 - 0 0 - 0 0 - 0 0 - 0 0 - 0 0 - 1 0 - 1 0 + 3 3 - 1 0 
5090, M - 0 0 - 0 0 - 0 0 - 0 0 - 0 0 - 0 0 - 0 0 - 0 0 - 3 1 + 3 1 
8095, F - 0 0 - 0 0 - 0 0 - 0 0 - 0 0 - 3 0 - 1 0 - 0 0 - 0 0 - 2 2 
8420, F - 0 0 - 0 0 - 0 0 - 0 0 - 0 0 - 0 0 - 1 0 - 0 0 - 0 0 + 3 3 
8492, F - 0 0 - 0 0 - 0 0 - 0 0 - 0 0 - 0 0 - 1 0 - 0 0 + 3 4 + 3 2 






























































 Control group, untreated Control group, treated (SD= 49-55) 
4266, F - 0 0 - 1 0 - 0 0 - 1 1 - 0 0 - 0 0 - 0 0 - 0 0 - 0 0 - 0 0 
5082, F + 3 2 + 3 3 + 3 2 + 2 2 + 1 0 + 0 0 + 1 1 - 0 0 - 0 0 - 0 0 
5084, F - 1 0 - 3 2 - 2 2 - 1 0 + 1 0 - 0 0 - 0 0 - 0 0 - 0 0 - 0 0 
5093, F - 1 0 - 4 3 - 2 1 - 2 1 - 1 0 - 0 0 - 1 1 - 0 0 - 0 0 - 0 0 
5527, M - 1 1 + 3 1 + 3 3 - 0 0 - 0 0 - 0 ni - 0 0 - 0 0 - 0 0 - 0 0 
6635, M - 0 0 - 0 0 - 0 0 - 1 1 - 0 0 - 0 0 - 3 3 - 0 0 - 0 0 - 0 0 

































































1: SAFC-technique: “-“= negative, “+”= positive (cysts were detected). 
2: Novitec®-ELISA: 0= negative, 1= slightly positive, 2= moderately positive, 3= high-grade positive, 4= very high-grade positive. 
3: SensPert®-Immunochromatography: 0= negative, 1= very slightly visible, 2= slightly visible, 3=visible, 4= well visible.  
ni: not interpretable. 
4: No. of positive dogs per each technique of totally 6 (therapeutic group) or 7 (control group) animals. 
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Fig. 1: Scheme of the experimental design with a therapeutic group (?, n= 6) and a control group 
(O, n= 7) of dogs infected with Giardia duodenalis and treated with ronidazole at different time 
points. F = Faecal sample, D= Desinfection, S = Shampooing. 
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